Mina Zarei, M.D. Dermatology - MOHS-Micrographic Surgery Medicare: Accepting Medicare Assignments Practice Location: 475 S State College Blvd, Brea, CA 92821 Phone: 148-707-5467 Fax: 714-870-6192 |
Karen Simpson, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 955 W Imperial Hwy Ste 200, Brea, CA 92821 Phone: 714-626-6310 Fax: 714-626-6320 |
Alexandra Edelman, MD Dermatology Medicare: Medicare Enrolled Practice Location: 955 W Imperial Hwy Ste 200, Brea, CA 92821 Phone: 714-626-6310 |
Zhe Hou, MD Dermatology - MOHS-Micrographic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3000 E Imperial Hwy Ste 150, Brea, CA 92821 Phone: 714-987-1818 |
Renee Cobos, MD Dermatology - MOHS-Micrographic Surgery Medicare: Accepting Medicare Assignments Practice Location: 475 S State College Blvd, Brea, CA 92821 Phone: 714-870-7546 Fax: 714-447-3376 |
Chiangyuan Chuck Liau, M.D.. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 875 N Brea Blvd, Brea, CA 92821 Phone: 714-529-6842 Fax: 714-256-1728 |
News Archive
Researchers at North Carolina State University have received a $3.5 million grant from the National Institute of Allergy and Infectious Disease (NIAID) to develop mathematical and statistical models that will aid in designing new treatment strategies for HIV patients.
Los Alamos National Laboratory researcher Bette Korber is part of an international team of investigators working to design and implement the first human trial of a mosaic HIV vaccine candidate. The vaccine represents a novel strategy for fighting the virus that causes AIDS by attempting to address one of the most daunting challenges in HIV vaccine design: the virus's extensive genetic diversity.
Tuberculosis (TB) has been present in humans since ancient times. The origins of the disease date back to the first domestication of cattle, and skeletal remains show prehistoric humans (4,000 B.C.) had TB. Although relatively rare in the United States, it is the single leading bacterial cause of death worldwide. Approximately 8 million people are infected each year and 2 million people die from TB.
GlaxoSmithKline has announced that its new generation H5N1 split antigen pre-pandemic influenza vaccine has been accepted for review by the Committee for Medicinal Products for Human Use (CHMP) in Europe.
An analysis of a large nationally representative longitudinal study by University of California San Diego Herbert Wertheim School of Public Health and Human Longevity Science report that starting tobacco products, including e-cigarettes, before the age of 18 is a major risk factor for people becoming daily cigarette smokers.
› Verified 7 days ago